Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners

Date14 June 2013
Pages68-81
Published date14 June 2013
DOIhttps://doi.org/10.1108/17449201311326943
AuthorCharlotte N.E. Tompkins
Subject MatterHealth & social care,Public policy & environmental management,Sociology
Exploring motivations to stop injecting in
English prisons: qualitative research with
former male prisoners
Charlotte N.E. Tompkins
Abstract
Purpose – This paper aims to explore the cessation of injecting amongst male drug users when in
prison in England and uncovers what influenced this behaviour and why.
Design/methodology/approach – Qualitative interviews were conducted with 30 male drug users on
release from prison to explore what happened to their injecting drug use in prison. The research was
conducted from a pragmatic harm reduction approach using grounded theory.
Findings – Not injecting in prison was identified as a pertinent finding and nine overarching themes
accounted for this decline. The themes often overlapped with one another, highlighting how the decision
not to inject when last in prison was multi-factorial. Running throughout the themes were participants’
concerns regarding the health and social risks attributed to injecting in prison, alongside an
appreciation of some of the rehabilitative measures and opportunities offered to injecting drug users
when in prison.
Originality/value – This qualitative research offers an updated perspective on illicit drug injecting in
prison in England from the view of drug users since health and prison policy changes in prescribing and
practice. It contributes to evidence suggesting that prisons can be used as a time of reprieve and
recovery from injecting drug use.
Keywords Injection drug use, Prisons, Prisoners, Men, Qualitative, Interviews, Harm reduction,
Public health, Grounded theory, Imprisonment, Drugs
Paper type Research paper
Introduction
The practice of injecting illicit drugs is considered high risk due to some of the potential health
and social consequences, particularly as use becomes more routine (Berridge and Robinson,
2003). For example, injecting is thought to be the main cause of health damage related to illicit
drug use in contemporary Europe (European Monitoring Centre for Drugs and Drug
Addiction, 2001; Towl,2006), encompassing physical and mental morbidity and an increased
risk of mortality through the early onset of disease or fatal drug overdose. Despite these risks,
injecting is a popular way of administering illicit drugs due to the instant ‘‘hit’’ seconds after
administration as the drugs quickly travel in the bloodstream to the brain (Neale, 2002) and the
lesser amount needed to obtain a hit in comparison to other administration routes.
Intravenously injecting in prison environments has been identified to carry high, sometimes
higher risks than community injecting (European Monitoring Centre for Drugs and Drug
Addiction, 2012; Ju
¨rgens et al., 2009; Shewan et al., 2005; World Health Organization,
2005). This is due to a number of reasons, including the reduced access to sterile injecting
materials in some prisons, which may result in the sharing of previously used (and therefore
possibly infected) injecting equipment (Hughes, 2001; Ju
¨rgens et al., 2009; Wright et al.,
2005). Indeed, prisons are high risk environments for the spread of blood borne viruses
such as HIV/AIDS and hepatitis (United Nations Office on Drugs and Crime, 2011), partly
due to unsterile injecting drug use and/or tattooing practices which may take place
PAGE 68
j
INTERNATIONAL JOURNAL OF PRISONER HEALTH
j
VOL. 9 NO. 2 2013, pp. 68-81, QEmerald Group Publishing Limited, ISSN 1744-9200 DOI 10.1108/17449201311326943
Charlotte N.E. Tompkinsis a
Research Fellow based at
Leeds Community
Healthcare NHS Trust,
Leeds, UK.
With thanks to the men who took
part and shared their stories,
to Dr Mitch Waterman,
Dr Anna Madill and
Dr Nat Wright. Thanks also to
the Harold Hyam Wingate
Foundation and the Max
Hamilton Research Fund,
University of Leeds. The views
expressed are those of the
author.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT